CD200 expression in human cultured bone marrow mesenchymal stem cells is induced by pro-osteogenic and pro-inflammatory cues
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
CD200 expression in human cultured bone marrow mesenchymal stem cells is induced by pro-osteogenic and pro-inflammatory cues
Authors
Keywords
-
Journal
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
Volume 20, Issue 4, Pages 655-665
Publisher
Wiley
Online
2016-01-17
DOI
10.1111/jcmm.12752
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- CD200R/CD200 Inhibits Osteoclastogenesis: New Mechanism of Osteoclast Control by Mesenchymal Stem Cells in Human
- (2013) Audrey Varin et al. PLoS One
- The noncanonical NF-κB pathway
- (2012) Shao-Cong Sun IMMUNOLOGICAL REVIEWS
- Regulation of bone and cartilage development by network between BMP signalling and transcription factors
- (2012) R. Nishimura et al. JOURNAL OF BIOCHEMISTRY
- Functional heterogeneity of mesenchymal stem cells: Implications for cell therapy
- (2012) Donald G. Phinney JOURNAL OF CELLULAR BIOCHEMISTRY
- Accumulation of p100, a Precursor of NF-κB2, Enhances Osteoblastic Differentiationin Vitroand Bone Formationin Vivoinaly/alyMice
- (2012) Yoshinori Seo et al. MOLECULAR ENDOCRINOLOGY
- CD200 Positive Human Mesenchymal Stem Cells Suppress TNF-Alpha Secretion from CD200 Receptor Positive Macrophage-Like Cells
- (2012) Mika Pietilä et al. PLoS One
- Differential Expression of Surface Markers in Mouse Bone Marrow Mesenchymal Stromal Cell Subpopulations with Distinct Lineage Commitment
- (2012) Maria Rostovskaya et al. PLoS One
- In Vivo Fate Mapping Identifies Mesenchymal Progenitor Cells
- (2011) Danka Grcevic et al. STEM CELLS
- Bone Marrow Mesenchymal Stem Cells: Historical Overview and Concepts
- (2010) Pierre Charbord HUMAN GENE THERAPY
- Novel functions for NFκB: inhibition of bone formation
- (2010) Susan A. Krum et al. Nature Reviews Rheumatology
- Consistent Osteoblastic Differentiation of Human Mesenchymal Stem Cells with Bone Morphogenetic Protein 4 and Low Serum
- (2010) Thomas Cordonnier et al. TISSUE ENGINEERING PART C-METHODS
- Interleukin-1β and tumor necrosis factor α inhibit chondrogenesis by human mesenchymal stem cells through NF-κB-dependent pathways
- (2009) N. Wehling et al. ARTHRITIS AND RHEUMATISM
- A Randomized, Double-Blind, Placebo-Controlled, Dose-Escalation Study of Intravenous Adult Human Mesenchymal Stem Cells (Prochymal) After Acute Myocardial Infarction
- (2009) Joshua M. Hare et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Role of a distal enhancer in the transcriptional responsiveness of the human CD200 gene to interferon-γ and tumor necrosis factor-α
- (2009) Zhiqi Chen et al. MOLECULAR IMMUNOLOGY
- Inhibition of osteoblastic bone formation by nuclear factor-κB
- (2009) Jia Chang et al. NATURE MEDICINE
- Specific Lineage-Priming of Bone Marrow Mesenchymal Stem Cells Provides the Molecular Framework for Their Plasticity
- (2009) Bruno Delorme et al. STEM CELLS
- The CD34-like protein PODXL and 6-integrin (CD49f) identify early progenitor MSCs with increased clonogenicity and migration to infarcted heart in mice
- (2008) R. H. Lee et al. BLOOD
- Shared Principles in NF-κB Signaling
- (2008) Matthew S. Hayden et al. CELL
- Heterogeneity of mesenchymal stromal cell preparations
- (2008) A.D. Ho et al. CYTOTHERAPY
- Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study
- (2008) Katarina Le Blanc et al. LANCET
- Proinflammatory cytokines inhibit osteogenic differentiation from stem cells: implications for bone repair during inflammation
- (2008) D.C. Lacey et al. OSTEOARTHRITIS AND CARTILAGE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started